Patupilone

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NamePatupilone
Drug Alias Name帕土匹隆Patupilonum帕妥匹隆Epothilone B帕土匹龙 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitosis inhibitorsTubulin modulatorsTubulin polymerisation promoters
TargetsTubulin
Therapy Area/IndicationsBrain metastasesHormone-Resistant Prostate NeoplasmsSolid tumours +[20] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[23] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesHunan Dino Pharmaceutical Co Ltd
Inactive CompaniesUniversity Of Medicine And Dentistry Of New JerseySidney Kimmel Cancer Center At Thomas Jefferson UniversityUniversity Of Southern California +[5] 
Active IndicationsSolid tumours
Inactive IndicationsBrain metastasesHormone-Resistant Prostate NeoplasmsNeoplasm Metastasis +[19] 

Other Information

ATC CodeN/A
Related LinksKEGG